Home Zoliget 30/4mg Tablet – Once-Daily Most-Powerful Oral Combo Before Insulin
Zoliget 30/4mg Tablet
Zoliget 30/4mg Tablet
Zoliget 30/4mg Tablet
Zoliget 30/4mg Tablet

Zoliget 30/4mg Tablet – Once-Daily Most-Powerful Oral Combo Before Insulin

  • Pioglitazone 30mg + Glimepiride 4mg ultimate-strength tablet
  • Final oral weapon for HbA1c >10% & severe resistance
In stock
9 People are viewing this right now
Sale price Rs.609.00 PKR
Add to Wishlist

Zoliget 30/4mg Tablet
Zoliget 30/4mg Tablet – Once-Daily Most-Powerful Oral Combo Before Insulin
Sale priceRs.609.00 PKR
SKU:
Categories: Medicines Tablets & Capsules
Tags: Extreme Diabetes Last Oral Combo Pioglitazone 30mg Glimepiride 4mg Zoliget 30/4
Zoliget 30/4mg Tablet

Zoliget 30/4mg Tablet – Once-Daily Most-Powerful Oral Combo Before Insulin

Rs.609.00

Zoliget 30/4mg Tablet – Pioglitazone 30mg + Glimepiride 4mg Final-Step Oral Therapy for Severe Insulin-Resistant Diabetes

Zoliget 30/4mg is the absolute highest-dose pioglitazone–glimepiride fixed combination available – reserved for patients with very long-duration type-2 diabetes, HbA1c persistently above 9–11%, marked beta-cell burnout and severe hepatic/peripheral insulin resistance. This single morning tablet unleashes a colossal 2.5–3.5% HbA1c reduction (often the largest drop achievable without injections), brings fasting glucose down by 90–130 mg/dL, and remains the last oral fortress before starting insulin in thousands of patients every year.

  • Highest oral HbA1c reduction possible (2.5–3.5%)
  • Last-line defence against starting insulin
  • Maximum reversal of insulin resistance & NASH
  • Single-tablet convenience despite extreme potency
  • Proven in the most difficult diabetes populations

  1. One Zoliget 30/4mg tablet every morning with first proper meal
  2. Swallow whole – never crush or take on empty stomach
  3. Eat carbohydrate-containing meals on schedule
  4. Usually prescribed only after failure of all lower-dose oral combos

Q1: Who actually needs the 30/4mg strength?
A1: Patients with diabetes >12–15 years, HbA1c >10% on maximum other orals, or South-Asian/Arab profiles with extreme insulin resistance.

Q2: How big is the sugar drop compared to 30/2mg?
A2: Extra 0.5–1.0% HbA1c and 30–50 mg/dL more fasting glucose lowering – frequently the difference that postpones insulin for another 2–5 years.

Q3: Is the hypo risk very high at 4mg glimepiride?
A3: Yes – up to 25–30% experience mild–moderate lows; always eat breakfast and carry fast sugar.

Q4: Still useful for fatty liver at this dose?
A4: Yes – 30–45mg pioglitazone range shows the most dramatic NASH resolution in trials.

Q5: When do doctors finally switch to insulin instead of 30/4mg?
A5: Only when HbA1c remains >9% despite perfect adherence and lifestyle, or if unacceptable weight gain/hypo occurs.

Pioglitazone HCl 30mg, Glimepiride 4mg, Lactose Monohydrate, Microcrystalline Cellulose, Croscarmellose Sodium, Magnesium Stearate, Opadry Pink

  • Take strictly once every morning with a substantial breakfast
  • Highest hypoglycaemia risk in the range – always carry glucose tablets/gel
  • Expect 4–8 kg weight gain & possible ankle swelling in first 6 months
  • Absolutely contraindicated in any degree of heart failure or active liver disease
  • Keep away from children

You may also like

Recently viewed products